Johnson & Johnson Innovation

About The Fund

Johnson & Johnson Innovation - JJDC, Inc. (JJDC) is the corporate venture capital arm of Johnson & Johnson. Founded in 1973 and headquartered in New Brunswick, New Jersey, JJDC embodies a long-standing commitment to the support of innovation across the global healthcare industry. JJDC invests in an array of sectors including but not limited to medical devices, diagnostics, pharmaceuticals, biotechnology, and consumer health products. They are an active investor in early-stage, seed, and later-stage ventures, demonstrating a broad spectrum of investment interests from nascent startups to more established growth companies. Their geographical footprint is extensive, supporting companies based in the United States, Europe, Asia, and Israel. The fund has historically focused on areas that align closely with Johnson & Johnson's existing business units, therefore ensuring strategic alignment and support for their portfolio companies beyond capital. They strongly value collaboration with entrepreneurs and innovators who are at the forefront of emerging technologies and solutions in healthcare and are aligned with their vision for the future of the industry. The sectors that the fund has a particular interest in also spans FinTech and financial services, HealthTech and fitness, logistics and distribution, and general healthcare and wellness markets. This equips them with a versatile portfolio aimed at leveraging synergy among varying facets of consumer and healthcare domains to foster comprehensive growth and progress within the industry. Their approach not only capitalizes on their financial resources but also leverages JJ's vast resources, experience, and global reach to guide the companies toward success.